U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Digital Health Advisory Committee
  5. Roster of the Digital Health Advisory Committee
  1. Digital Health Advisory Committee

Roster of the Digital Health Advisory Committee

November 20-21, 2024: Advisory Committee Meeting 

FDA plans to hold a two-day in person meeting with simultaneous webcast of the Digital Health Advisory Committee on November 20-21, 2024 in Gaithersburg, MD, to discuss total product lifecycle considerations for Generative AI-enabled devices. Topics planned to be addressed include how the use of Generative AI may impact safety and effectiveness of medical devices enabled with this technology. The FDA is seeking expert recommendations to help assess the potential risks and benefits of these devices. Further details will be provided in the Federal Register announcement that will be published in the upcoming months in accordance with FDA’s policies and procedures for Advisory Committee Meetings. 

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 0
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Ami B. Bhatt, M.D.
Expertise: Digital Health; Cardiology
Term: 08/01/2024 – 07/31/2028
Chief Innovation Officer
American College of Cardiology
2400 M street NW
Washington DC 20037

Designated Federal Officer
Serina A. Hunter-Thomas, M.S.A, B.S.N., R.N.
Center for Devices and Radiological Health
Office of Management
10903 New Hampshire Avenue
WO Bldg. 66 Rm 5211
Silver Spring, Maryland 20993
Office: (240) 402-5771

Ray Dorsey, M.D., M.B.A.
Expertise: Telemedicine; Digital Measures
Term: 08/01/2024 – 07/31/2027
David M. Levy Professor of Neurology
University of Rochester
265 Crittenden Blvd. CU 420694
Rochester, NY 14642

Yaniv Kerem, M.D.
Expertise: Emergency Medicine; Clinical Informatics
Term: 08/01/2024 – 07/31/2026
Physician, Department of Emergency Medicine
Kaiser Permanente Redwood City Medical Center
1100 Veterans Blvd.
Redwood City, CA 94063

Joyce C. Ho, Ph.D.
Expertise: Machine Learning; Chronic Diseases
Term: 08/01/2024 – 07/31/2027
Associate Professor
Computer Science Department
Emory University
400 Dowman Drive
Atlanta, GA 30322

Jessica L. Jackson, Ph.D. 
Expertise: Psychology; Digital Mental Health
Term: 08/01/2024 – 07/31/2026
Founder and CEO
Therapy Is For Everyone 
Psychological & Consultation, PLLC
Houston, TX 77010

Thomas M. Maddox, M.D., SM
Expertise: Healthcare Innovation
Term: 08/01/2024 – 07/31/2028
Professor of Medicine (Cardiology)
Washington University School of Medicine
4590 Nash Way
Mailstop 90-29-933
St. Louis, MO 63110

Chevon M. Rariy, M.D.
Expertise: Digital Health
Term: 08/01/2024 – 07/31/2028
Chief Health Officer and SVP Digital Health
Oncology Care Partners
333 11th Ave. South, Suite 300
Nashville, TN 37203

Laura M. Stanley, Ph.D., CPE
Expertise: Digital Health; Human System Integration
Term: 08/01/2024 – 07/31/2027
Associate Professor
School of Computing
Montana State University
Gianforte School of Computing
354 Barnard Hall
Bozeman, MT 59717

Melissa Denise Clarkson, Ph.D.*
Expertise: Biomedical Informatics; Patient Advocacy
Term: 08/01/2024 – 07/31/2028
Assistant Professor
Department of Internal Medicine
University of Kentucky College of Medicine
230C MDS Building
725 Rose Street
Lexington, KY 40536

* Consumer Representative
** Industry Representative

**As described in the charter for this committee, the membership includes no single designated industry representative, the Commissioner or designee may select an industry representative from a pool of individuals nominated by industry to serve temporarily as a nonvoting member who are identified with industry interests. The list of individuals in the pool can be viewed here

 

Back to Top